These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13867648)

  • 1. The pharmacological properties of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (Mebutamate, W-583), a new centrally acting blood pressure lowering agent.
    BERGER FM; DOUGLAS JF; KLETZKIN M; LUDWIG BJ; MARGOLIN S
    J Pharmacol Exp Ther; 1961 Dec; 134():356-65. PubMed ID: 13867648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the hypotensive effect of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (mebutamate)].
    MARANGONI R; MELLONI GF
    Atti Soc Ital Cardiol; 1962 Jun 1-3; 2():269-71. PubMed ID: 13932756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the hypotensive action of mebutamate (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)].
    MELLONI G; MARANGONI R
    Minerva Med; 1962 Apr; 53():1085-100. PubMed ID: 14472419
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new antihypertensive agent with central action: 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (mebutamate)].
    CUGURRA F
    Clin Ter; 1962 Jun; 22():1046-54. PubMed ID: 13882583
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action on the circulation of 2-methyl-2-butyl-1,3-propanediol dicarbamate (mebutamate)].
    TACCARDI B; MACCARI M; VALLI A
    Arch Ital Sci Farmacol; 1961 Jul; 11():207-15. PubMed ID: 13918847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical research with a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate (mebutamate)].
    ANNONI G; MAGGI A
    Minerva Med; 1962 Apr; 53():1108-13. PubMed ID: 13861699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of a new hypotensive drug: 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate].
    POZZI LL; CAGNONI M
    Gazz Med Ital; 1963 Jan; 122():1-7. PubMed ID: 13985873
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations on a new product with hypotensive action (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)].
    BOSISIO P; SCAGLIETTI C
    Minerva Med; 1962 Apr; 53():1101-6. PubMed ID: 13871584
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the antihypertensive effectiveness of a new propanediol dicarbamate (W-583).
    DUARTE C; BREST AN; KODAMA R; NASO F; MOYER JH
    Curr Ther Res Clin Exp; 1960 May; 2():148-52. PubMed ID: 13818273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary observations on a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate].
    GRANDINETTI P
    Minerva Med; 1962 Apr; 53():1113-4. PubMed ID: 13901099
    [No Abstract]   [Full Text] [Related]  

  • 11. OBSERVATIONS ON THE ANTIHYPERTENSIVE AND SEDATIVE EFFECTS OF MEBUTAMATE, MEPROBAMATE AND RESERPINE.
    MORIN Y; TURMEL L; GRANTHAM H; FORTIER J
    Can Med Assoc J; 1963 Nov; 89(19):980-2. PubMed ID: 14076165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of arterial hypertension with 2-methyl-2-sec-butyl-1, 3-propanediol dicarbamate (mebutamate)].
    BUONINCONTI R
    Gazz Med Ital; 1963 Feb; 122():54-6. PubMed ID: 14016864
    [No Abstract]   [Full Text] [Related]  

  • 13. [REMOTE CLINICAL EVALUATION OF THE HYPOTENSIVE ACTION OF 2-METHYL-2-SEC-BUTYL-1-3-PROPANDIOL BICARBAMATE (MEBUTAMATE)].
    TUDINI F
    Gazz Med Ital; 1963 Nov; 122():345-51. PubMed ID: 14117175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Some aspects of the general pharmacology of 2,2-bis(carbamoyloxymethyl)-3-methylpentane (mebutamate)].
    PRETI M
    Arch Ital Sci Farmacol; 1961 Jul; 11():216-24. PubMed ID: 14488675
    [No Abstract]   [Full Text] [Related]  

  • 15. CLINICAL EVALUATION OF MEBUTAMATE, A NEW ANTIHYPERTENSIVE AGENT.
    JANNEY JG; PIERRE GD; THURMANN M; UTLEY JH; AYKENT Y; CASTRO J
    Clin Pharmacol Ther; 1963; 4():720-7. PubMed ID: 14079249
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTIHYPERTENSIVE THERAPY WITH COMBINED MEBUTAMATE AND HYDROCHLOROTHIAZIDE.
    CARTER FS
    Clin Med (Northfield); 1964 Jul; 71():1216-22. PubMed ID: 15446192
    [No Abstract]   [Full Text] [Related]  

  • 17. Double blind evaluation of a new propanediol derivative (mebutamate) as a peripheral vasodilator.
    LUMISH SH; BLYN C; NODINE JH
    Curr Ther Res Clin Exp; 1961 Nov; 3():485-94. PubMed ID: 14467333
    [No Abstract]   [Full Text] [Related]  

  • 18. THIO ANALOGS OF CARISOPRODOL (N-ISOPROPYL-2-METHYL-2-PROPYL-1,3-PROPANEDIOL DICARBAMATE).
    LEAFFER MA; SKINNER WA
    J Med Chem; 1965 Mar; 8():208-12. PubMed ID: 14332662
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON A SERIES OF DICARBAMATES OF 2,2-DISUBSTITUTED PROPANE-1,3-DIOLES].
    FERRARI G; CASAGRANDE C
    Farmaco Sci; 1963 Oct; 18():780-92. PubMed ID: 14113065
    [No Abstract]   [Full Text] [Related]  

  • 20. HYPERTENSION CONTROL; MEBUTAMATE AND HYDROCHLOROTHIAZIDE.
    ROEDIGER PM; PUSCHAK TB; HUTCHISON JC
    Pa Med J; 1964 Jan; 67():32-5. PubMed ID: 14104539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.